JANX
Janux Therapeutics (JANX)
$55
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$50.50
Daily low
$46.89
Price at open
$46.95
52 Week High
$65.60
52 Week Low
$5.65
Market cap
2.6B
Dividend yield
0.00%
Volume
743,598
Avg. volume
622,492
P/E ratio
-54.14
Janux Therapeutics News
Details
Daily high
$50.50
Daily low
$46.89
Price at open
$46.95
52 Week High
$65.60
52 Week Low
$5.65
Market cap
2.6B
Dividend yield
0.00%
Volume
743,598
Avg. volume
622,492
P/E ratio
-54.14